Moody Aldrich Partners’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-85,479	Closed	-$2.49M	–	110
2018 Q4	$2.49M	Buy	+85,479	New	+$2.49M	0.82%	51
2016 Q2	–	Sell	-6,640	Closed	-$249K	–	94
2016 Q1	$249K	Buy	+6,640	New	+$249K	0.52%	82